Delivery Order SPE2DB24D2012-SPE2DB25FBVEE

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,557,701,857 units of Nateglinide 120 mg tablets, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The firm-fixed-price delivery order, valued at $1,881.64, has a completion date of July 5, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,037.49 firm fixed-price delivery order is for the supply of 4,566,825,872 units of the drug Nateglinide 120 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,378.49 Firm Fixed Price Delivery Order contract provides 4,566,554,740 units of the medication Nateglinide 60 mg Tablets. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
This federal contract award, valued at $1,930.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is a delivery order contract for the supply of 4,565,237,639 units of the pharmaceutical product Nateglinide 60 mg Tablet. The contract has an ultimate completion date of July 25, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nateglinide 60 mg tablets. The contract, valued at $2,237.92, was awarded on August 2, 2021 and has an ultimate completion date of August 3, 2021. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,409.25 firm fixed-price delivery order is for the provision of Nateglinide 120 mg tablets to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,216.66 firm fixed-price delivery order is for the supply of 4,562,449,360 Nateglinide 60 mg tablets. The award has an ultimate completion date of October 12, 2023 and was made on October 11, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,020.03, is for the delivery of 4,563,324,213 units of the pharmaceutical drug Nateglinide 120 mg tablets in 100-count bottles. The award has an ultimate completion date of January 16, 2024 and is a Firm Fixed Price Delivery Order contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,634.67 firm-fixed-price contract is for the delivery of Nateglinide 60 mg tablets, a type of oral antidiabetic medication. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,133.05 firm-fixed-price delivery order is for the supply of Nateglinide 60 mg Tablet unit doses, with a completion date of September 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery vehicles (IDVs) to provide a wide range of medical commodities,...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB25FBVEE
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for the supply of 4,567,074 units of Nateglinide 120 mg tablets to the agency. The contract has a total ceiling value of $15,880.84 and is a firm fixed-price arrangement. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 10:18 AM